Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MNKD $0.61 0.1406 +29.97%
GALE $0.31 0.0360 +13.19%
IDRA $1.90 0.2000 +11.76%
ZIOP $5.80 0.6000 +11.54%
IMMU $2.29 0.1700 +8.02%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

VRML $1.04 -0.1000 -8.77%
GTXI $0.86 -0.0369 -4.10%
CYTR $0.53 -0.0202 -3.69%
UTHR $113.04 -3.4400 -2.95%
ARQL $1.42 -0.0300 -2.07%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

Treated for Cancer, Two Men Now Appear Free of HIV

(NBC News) July 3, 2013 - Two men who had grueling bone marrow treatments for cancer are enjoying a happy side effect: They appear free of the AIDS virus, researchers reported on Wednesday.
read article 

Roche Gets FDA Priority Review for Leukemia Drug Obinutuzumab

(Morningstar/Dow Jones Newswires) July 3, 2013 - Roche Holding AG said Wednesday the U.S. Food and Drug Administration has granted a priority review for its obinutuzumab drug in the treatment of chronic lymphocytic leukemia, one of the most common forms of blood cancer.
read article 

Pierce Brosnan’s Daughter Charlotte Dies From Ovarian Cancer

(ABC News) July 2, 2013 - Pierce Brosnan’s daughter Charlotte has died after a three-year battle with the same disease that also claimed her mother’s life more than 20 years ago.
read article 

Dialysis Stocks Hit by Proposed U.S. Reimbursement Cuts

(Reuters) July 2, 2013 - A proposal to slash reimbursements to kidney dialysis centers in the United States drove down shares of Fresenius Medical Care AG and Davita Healthcare Partners Inc, two of the world's leading providers of dialysis services.
read article 

Pfizer’s Eliquis Stops Blood Clots as Well as Standard

(Bloomberg) July 1, 2013 - Eliquis, the blood thinner sold by Pfizer Inc. and Bristol-Myers Squibb Co., was as good as the current standard of care in preventing blood clots and with fewer bleeding complications, according to a study.
read article 

How Biotechs Got Hot

(Wall Street Journal) July 1, 2013 - Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes.
read article (paid subscription required) 

International Conference to Take a Fresh Look at a Cancer-Causing Protein

(University of New Mexico Cancer Center) July 1, 2013 - MYB Conference to foster new research efforts to study protein mutation that causes cancer.
read press release 

Cancer Discovery Scores High in New Journal Rankings Report

(AACR) June 26, 2013 - Cancer Discovery, a journal of the American Association for Cancer Research (AACR), ranked ninth of 196 oncology-focused, peer-reviewed journals in terms of impact factor, according to the latest Journal Citation Report from Thomson-Reuters, the industry standard for journal impact measurement.
read press release 

GE Healthcare Research Determines Bad Habits Add $33.9 Billion to Annual Global Cost of Cancer

(Daily Finance) July 2, 2013 - GE Healthcare today released secondary research findings indicating that bad habits and lifestyle choices are contributing approximately $33.9 billion annually to the costs related to cancer.
read article 

New Clinical Practice Guidelines Address Diagnosis, Staging of Esophageal Cancer

(STS) July 1, 2013 - The Society of Thoracic Surgeons (STS) has released a set of clinical practice guidelines to address current and changing factors that affect the diagnosis and treatment of localized esophageal cancer.
read press release 

ARIAD Announces Marketing Authorization for Iclusig® (ponatinib) in the European Union

(TheStreet) July 2, 2013 - ARIAD Pharmaceuticals, Inc. today announced that the European Commission (EC) has granted a marketing authorization for Iclusig® (ponatinib) as an orphan medicinal product for two indications:
read article 

Roche Buys U.S. Blood-Testing Firm for Initial $220 Million

(Reuters) July 2, 2013 - Swiss drugmaker Roche Holding AG is buying Constitution Medical Investors (CMI), the U.S. developer of a testing system for blood diseases like anemia and leukemia, for an upfront $220 million, plus further contingent payments.
read article 

How Onyx Transformed Itself Into a Target

(Wall Street Journal) July 1, 2013 - Onyx Pharmaceuticals has developed itself from a struggling biotech company to a $10 billion acquisition target in just a few years.
read article (paid subscription required) 

Onyx Investors Shouldn't Count on Bayer Buying

(Wall Street Journal) July 1, 2013 - In biotech, deal valuations have a habit of defying gravity.
read article (paid subscription required) 

VentiRx Pharmaceuticals Initiates the ACTIVE8 Phase 2 Clinical Trial Evaluating VTX-2337 in Combination with Cetuximab and Chemotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

(Sacramento Bee) July 2, 2013 - VentiRx Pharmaceuticals, Inc. announced today the initiation of the ACTIVE8 clinical trial, a randomized, placebo-controlled, Phase 2 trial evaluating VTX-2337 in combination with a standard of care regimen, cetuximab, platinum and 5 Fluorouracil (5-FU), in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
read article 

Array BioPharma Initiates MEK162 Phase 3 MILO Study Triggering Milestone Payment

(MarketWatch July 2, 2013 - Array BioPharma Inc. announced today that a $5 million milestone was achieved after the start of Array's Phase 3 clinical trial in patients with low-grade serous ovarian cancer (LGSOC).
read article 

Researchers Find Two New Methods to Determine ALK Status

(IASLC) July 1, 2013 - Tests continue trend in personalized medicine for lung cancer patients.
read press release 

Study Shows SBRT for Stage I NSCLC Safe and Effective

(IASLC) July 1, 2013 - Data collected from 582 non-small cell lung cancer patients who underwent stereotactic body radiotherapy.
read press release 

Cancer Discovery: Montreal, Calgary Researchers Find Novel Disease Spreads

(Edmonton Journal) July 1, 2013 - Canadian researchers have achieved a breakthrough in understanding an entirely new way cancer spreads — by hijacking the white blood cells that usually fight diseases.
read article 

Can Long-Term Night Work Raise Breast Cancer Risk?

(U.S. News & World Report/HealthDay News) July 2, 2013 - Women who worked later hours for 30 years or more had double the chances of disease, study found.
read article 

Red Meat Tied to Worse Colon Cancer Outcomes: Study

(Reuters Health) July 1, 2013 - People who report eating the most red and processed meat before being diagnosed with colon cancer are more likely to die during the next eight years, according to a new study.
read article 

New Understanding of Oral HPV Infections in Healthy Men

(NCI News Note) July 2, 2013 - Scientists report that newly acquired oral HPV infections in healthy men are uncommon and, when present, tend to go away within one year.
read article 

Thyroid Cancer-Rising Most Rapidly Among Insured Patients

(Norris Cotton Cancer Center) July 1, 2013 - The rapid increase in papillary thyroid cancer in the US, may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center, instead it may be linked to an increase in the diagnosis of pre-cancerous conditions and to a person's insurance status.
read press release 

Viewpoint: Reforming the Payment System for Medical Oncology

(JAMA) July 1, 2013 - Oncologist Peter B. Bach, MD, of Memorial Sloan-Kettering Cancer Center suggests three different payment approaches as possible solutions to the current financing method for physician-administered oncology drugs.
read article 

New Test May Help More Breast Cancer Patients Avoid Chemo

(Pharma Times UK) July 2, 2013 - A greater number of patients with breast cancer could be spared chemotherapy to reduce their risk of the disease returning, after UK scientists developed a more accurate genetic test to determine the likelihood of recurrence.
read article